Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas

Andres A. Roma, Cristina Magi-Galluzzi, Ming Zhou

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Context. - Renal angiomyolipoma is a tumor composed of varying amounts of fat, smooth muscle, and blood vessels. Characteristically, tumor cells express melanocytic markers such as HMB-45 and Melan-A. Recently, several other markers have been described as having excellent diagnostic sensitivity in cutaneous melanocytic lesions. Objectives. - To compare the sensitivities of 5 melanocytic markers in renal angiomyolipoma and to study the expression patterns of these markers in the 3 different components of angiomyolipoma. Design. - A tissue microarray of 20 renal angiomyolipomas was constructed. For each case, 3 cores containing fat, blood vessels, and smooth muscle were taken. The tissue microarray was then stained for HMB-45, Melan-A, tyrosinase, NK1-C3, and CD117. Results. - HMB-45 was positive in 95%, Melan-A in 85%, NK1-C3 in 70%, tyrosinase in 50%, and CD117 in 40% of the cases. All (20/20) were positive for HMB-45 and Melan-A combined. These 5 markers had different sensitivities in the 3 components. HMB-45 was positive in 90%, 85%, and 80% of fat, smooth muscle, and blood vessel components, respectively; Melan-A in 70%, 60%, and 40%; NK1-C3 in 55%, 55%, and 45%; tyrosinase in 30%, 40%, and 10%; and CD117 in 20%, 40%, and 10%, respectively, of these 3 components. Conclusions. - HMB-45 and Melan-A combined were positive in 100% of the renal angiomyolipomas. We recommend the use of these 2 markers in the workup of this entity, including those with predominancy 1 component. Other melanocytic markers are of limited use. A tissue block comprising predominantly fat or smooth muscle components should be used when performing melanocytic marker immunostain.

Original languageEnglish (US)
Pages (from-to)122-125
Number of pages4
JournalArchives of Pathology and Laboratory Medicine
Volume131
Issue number1
StatePublished - Jan 1 2007

Fingerprint

MART-1 Antigen
Angiomyolipoma
Blood Vessels
Kidney
Smooth Muscle
Monophenol Monooxygenase
Fats
Neoplasms
Skin

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. / Roma, Andres A.; Magi-Galluzzi, Cristina; Zhou, Ming.

In: Archives of Pathology and Laboratory Medicine, Vol. 131, No. 1, 01.01.2007, p. 122-125.

Research output: Contribution to journalArticle

@article{bdb9097a9b6d47a2a22c36e961f1e49f,
title = "Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas",
abstract = "Context. - Renal angiomyolipoma is a tumor composed of varying amounts of fat, smooth muscle, and blood vessels. Characteristically, tumor cells express melanocytic markers such as HMB-45 and Melan-A. Recently, several other markers have been described as having excellent diagnostic sensitivity in cutaneous melanocytic lesions. Objectives. - To compare the sensitivities of 5 melanocytic markers in renal angiomyolipoma and to study the expression patterns of these markers in the 3 different components of angiomyolipoma. Design. - A tissue microarray of 20 renal angiomyolipomas was constructed. For each case, 3 cores containing fat, blood vessels, and smooth muscle were taken. The tissue microarray was then stained for HMB-45, Melan-A, tyrosinase, NK1-C3, and CD117. Results. - HMB-45 was positive in 95{\%}, Melan-A in 85{\%}, NK1-C3 in 70{\%}, tyrosinase in 50{\%}, and CD117 in 40{\%} of the cases. All (20/20) were positive for HMB-45 and Melan-A combined. These 5 markers had different sensitivities in the 3 components. HMB-45 was positive in 90{\%}, 85{\%}, and 80{\%} of fat, smooth muscle, and blood vessel components, respectively; Melan-A in 70{\%}, 60{\%}, and 40{\%}; NK1-C3 in 55{\%}, 55{\%}, and 45{\%}; tyrosinase in 30{\%}, 40{\%}, and 10{\%}; and CD117 in 20{\%}, 40{\%}, and 10{\%}, respectively, of these 3 components. Conclusions. - HMB-45 and Melan-A combined were positive in 100{\%} of the renal angiomyolipomas. We recommend the use of these 2 markers in the workup of this entity, including those with predominancy 1 component. Other melanocytic markers are of limited use. A tissue block comprising predominantly fat or smooth muscle components should be used when performing melanocytic marker immunostain.",
author = "Roma, {Andres A.} and Cristina Magi-Galluzzi and Ming Zhou",
year = "2007",
month = "1",
day = "1",
language = "English (US)",
volume = "131",
pages = "122--125",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "1",

}

TY - JOUR

T1 - Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas

AU - Roma, Andres A.

AU - Magi-Galluzzi, Cristina

AU - Zhou, Ming

PY - 2007/1/1

Y1 - 2007/1/1

N2 - Context. - Renal angiomyolipoma is a tumor composed of varying amounts of fat, smooth muscle, and blood vessels. Characteristically, tumor cells express melanocytic markers such as HMB-45 and Melan-A. Recently, several other markers have been described as having excellent diagnostic sensitivity in cutaneous melanocytic lesions. Objectives. - To compare the sensitivities of 5 melanocytic markers in renal angiomyolipoma and to study the expression patterns of these markers in the 3 different components of angiomyolipoma. Design. - A tissue microarray of 20 renal angiomyolipomas was constructed. For each case, 3 cores containing fat, blood vessels, and smooth muscle were taken. The tissue microarray was then stained for HMB-45, Melan-A, tyrosinase, NK1-C3, and CD117. Results. - HMB-45 was positive in 95%, Melan-A in 85%, NK1-C3 in 70%, tyrosinase in 50%, and CD117 in 40% of the cases. All (20/20) were positive for HMB-45 and Melan-A combined. These 5 markers had different sensitivities in the 3 components. HMB-45 was positive in 90%, 85%, and 80% of fat, smooth muscle, and blood vessel components, respectively; Melan-A in 70%, 60%, and 40%; NK1-C3 in 55%, 55%, and 45%; tyrosinase in 30%, 40%, and 10%; and CD117 in 20%, 40%, and 10%, respectively, of these 3 components. Conclusions. - HMB-45 and Melan-A combined were positive in 100% of the renal angiomyolipomas. We recommend the use of these 2 markers in the workup of this entity, including those with predominancy 1 component. Other melanocytic markers are of limited use. A tissue block comprising predominantly fat or smooth muscle components should be used when performing melanocytic marker immunostain.

AB - Context. - Renal angiomyolipoma is a tumor composed of varying amounts of fat, smooth muscle, and blood vessels. Characteristically, tumor cells express melanocytic markers such as HMB-45 and Melan-A. Recently, several other markers have been described as having excellent diagnostic sensitivity in cutaneous melanocytic lesions. Objectives. - To compare the sensitivities of 5 melanocytic markers in renal angiomyolipoma and to study the expression patterns of these markers in the 3 different components of angiomyolipoma. Design. - A tissue microarray of 20 renal angiomyolipomas was constructed. For each case, 3 cores containing fat, blood vessels, and smooth muscle were taken. The tissue microarray was then stained for HMB-45, Melan-A, tyrosinase, NK1-C3, and CD117. Results. - HMB-45 was positive in 95%, Melan-A in 85%, NK1-C3 in 70%, tyrosinase in 50%, and CD117 in 40% of the cases. All (20/20) were positive for HMB-45 and Melan-A combined. These 5 markers had different sensitivities in the 3 components. HMB-45 was positive in 90%, 85%, and 80% of fat, smooth muscle, and blood vessel components, respectively; Melan-A in 70%, 60%, and 40%; NK1-C3 in 55%, 55%, and 45%; tyrosinase in 30%, 40%, and 10%; and CD117 in 20%, 40%, and 10%, respectively, of these 3 components. Conclusions. - HMB-45 and Melan-A combined were positive in 100% of the renal angiomyolipomas. We recommend the use of these 2 markers in the workup of this entity, including those with predominancy 1 component. Other melanocytic markers are of limited use. A tissue block comprising predominantly fat or smooth muscle components should be used when performing melanocytic marker immunostain.

UR - http://www.scopus.com/inward/record.url?scp=33846638428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846638428&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 122

EP - 125

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 1

ER -